Correlation Between Spyre Therapeutics and Hudson Pacific

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Hudson Pacific at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Hudson Pacific into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Hudson Pacific Properties, you can compare the effects of market volatilities on Spyre Therapeutics and Hudson Pacific and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Hudson Pacific. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Hudson Pacific.

Diversification Opportunities for Spyre Therapeutics and Hudson Pacific

0.02

Correlation Coefficient

Spyre Therapeutics  Hudson Pacific

Significant diversification

The 3 months correlation between Spyre and Hudson is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Hudson Pacific Properties in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hudson Pacific Properties and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Hudson Pacific. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hudson Pacific Properties has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Hudson Pacific go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Hudson Pacific

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Hudson Pacific. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.25 times less risky than Hudson Pacific. The stock trades about -0.13 of its potential returns per unit of risk. The Hudson Pacific Properties is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  432.00  in Hudson Pacific Properties on September 1, 2024 and sell it today you would lose (47.00) from holding Hudson Pacific Properties or give up 10.88% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Hudson Pacific Properties

Spyre Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Hudson Pacific Properties

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hudson Pacific Properties has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Spyre Therapeutics and Hudson Pacific

The main advantage of trading using opposite Spyre Therapeutics and Hudson Pacific positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Hudson Pacific can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hudson Pacific will offset losses from the drop in Hudson Pacific's long position.

The idea behind Spyre Therapeutics and Hudson Pacific Properties pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.